… clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled …
… , new or worsening signs or symptoms of coronary heart … events of symptomatic hypoglycemia were calculated using … of hypoglycemia and adverse events of severe hypoglycemia…..... Read More